Kaplan-Meier estimate of OS and RFS by assigned treatment and cytogenetic pattern.

Panels A and B are OS; panels C and D are RFS. Survival estimates include only patients evaluable for cytogenetic pattern (n = 163) defined as follows: Favorable, inv16/t(16;16), t(15;17) with or without other abnormalities, t(8;21) lacking del(9q) or complex karyotype; intermediate, normal karyotype, +8, +6, del(12p); unfavorable, −5/del(5q), −7/del(7q), inv(3q), abn 11q, abn 20q, t(9;22), abn 17p, and complex karyotype (> 3 abnormalities). Tick marks indicate censored observations.